Brinker Capital’s Repligen RGEN Stock Holding History

Brinker Capital’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,743	Closed	-$458K	–	978
2020 Q1	$458K	Buy	4,743 +78	+2%	+$7.53K	0.02%	664
2019 Q4	$432K	Buy	4,665 +413	+10%	+$34.7K	0.01%	761
2019 Q3	$326K	Buy	+4,252	New	+$372K	0.01%	797

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Brinker Capital's RGEN Position: Q2 2020 in Review

Brinker Capital sold out of Repligen (RGEN) in Q2 2020, closing a stake of 4,743 shares — an estimated $458K sold.

Brinker Capital first reported a position in RGEN in Q3 2019 and held it in 3 quarters. The position peaked at $458K in Q1 2020. 370 funds tracked by Wall St. Rank hold RGEN as of Q2 2020.

Brinker Capital reported no remaining Repligen position as of Q2 2020 after selling out during the quarter.
Brinker Capital sold 4,743 Repligen shares in Q2 2020, an estimated $458K.
Brinker Capital first reported a position in Repligen in Q3 2019 and held it in 3 quarters.
Brinker Capital's Repligen position peaked at $458K in Q1 2020.
370 funds tracked by Wall St. Rank held Repligen as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.